Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...
A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the first in Arizona treated with a new immune cell therapy known as TECELRA at ...
A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...
A recent analysis reveals that the incidence rates of soft tissue sarcomas - cancers in muscle, fat, blood vessels, nerves, and tendons - are lower in young U.S. active-duty military servicemen ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — A novel T-cell receptor therapy showed promising antitumor activity in patients with advanced soft ...
Clear cell sarcoma is an uncommon and aggressive soft tissue tumour that most often arises in the tendons and aponeuroses of young adults. It is distinguished by its melanocytic features and, in many ...
Soft tissue sarcoma (STS) is a rare type of cancer that can quietly grow in the connective tissues of the body—such as fat, muscles, nerves, blood vessels, or beneath the skin. Although it represents ...
Please provide your email address to receive an email when new articles are posted on . American Society for Radiation Oncology issued its first clinical guideline for sarcoma. The guideline — ...
Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...
A new editorial was published in Volume 16 of Oncotarget on July 16, 2025, titled "microRNAs in soft tissue sarcoma: State of the art and barriers to translation." In this article, Elizaveta K.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results